China Resources Pharmaceutical Group
3320.HK
#3848
Rank
โ‚ฌ3.09 B
Marketcap
0,49ย โ‚ฌ
Share price
2.32%
Change (1 day)
-11.10%
Change (1 year)

Revenue for China Resources Pharmaceutical Group (3320.HK)

Revenue in 2025: โ‚ฌ33.76 Billion

According to China Resources Pharmaceutical Group's latest financial reports the company's current revenue (TTM ) is โ‚ฌ33.76 Billion. In 2025 the company made a revenue of โ‚ฌ33.76 Billion an increase over the revenue in the year 2024 that were of โ‚ฌ30.93 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for China Resources Pharmaceutical Group from 2022 to 2025

Annual revenue

Year Revenue Change
2025โ‚ฌ33.76 B9.13%
2024โ‚ฌ30.93 B1.99%
2023โ‚ฌ30.33 B9.43%
2022โ‚ฌ27.71 B